激素治疗梅尼埃病给药途径的研究进展
刘慧;邢巍巍;
1:辽宁医学院附属第一医院耳鼻咽喉-头颈外科耳科病区
1 Sajjadi H,Paparella MM.Meniere’s disease[J].Lancet,2008,372:406.
2 Thai-Van H,Bounaix MJ,Fraysse B.Meniere’s disease:pathophysiologyand treatment[J].Drugs,2001,61:1 089.
3 牛雷芳,刘博.梅尼埃病研究新动态[J].国际耳鼻咽喉头颈外科杂志,2009,33:132.
4 Trune DR,Canlon B.Corticosteroid therapy for hearing and balance disorders[J].The Anatomical Record,2012,295:1 928.
5 Tabuchi K,Nakamagoe M,Nishimura B,et al.Protective effects of corticosteroids and neurosteroids on cochlear injury[J].Medicinal Chemistry,2011,7:140.
6 张志坚,华清泉,王新春,等.全身应用联合鼓室注射糖皮质激素治疗重度和极度突发性聋[J].听力学及言语疾病杂志,2012,20:450.
7 Greco A,Gallo A,Fusconi M,et al.Meniere's disease might be an autoimmune condition[J].Autoimmunity Reviews,2012,11:731.
8 Hoffer ME,Balough BJ,Gottshall KR.Delivery of drugs to the inner ear[J].Curr Opin Otolaryngol Head Neck Surg,2006,14:329.
9 张志坚,王新春,廖华,等.糖皮质激素的不同给药途径及时机对重度和极重度突发性聋疗效的影响[J].听力学及言语疾病杂志,2011,519:529.
10 Hoskison E,Daniel M,Al-Zahid S,et al.Drug delivery to the ear[J].Therapeutic Delivery,2013,4:115.
11 McCall AA,Swan EE,Borenstein JT,et al.,Drug delivery for treatment of inner ear disease:current state of knowledge[J].Ear Hear,2010,31:156.
12 Fulya O,Omer FU,Ahmet A.Evaluation of the effect dexamethasone in experimentally induced endolymphatic hydrops in guinea pigs[J].American Journal of Otolaryngology-Head and Neck Medicine and Surgery,2008,29:88.
13 Trune DR,Canlon B.Corticosteroid therapy for hearing and balance disorders[J].The Anatomical Record,2012,295:1 928.
14 Hamid M,Trune D.Issues,indications,and controversies regarding intratympanic steroid perfusion[J].Curr Opin Otolaryngol Head Neck Surg,2008,16:434.
15 方袆,马芙蓉.类固醇激素鼓室内给药治疗内耳疾病的基础与临床研究[J].听力学及言语疾病杂志,2011,19:181.
16 Carlos H,Guillermo P,Jose M.Transtympanic steroids for Meniere’s disease[J].Otology Neurotology,2010,31:162.
17 Itoh A,Sakata E.Treatment of vestibular disorders[J].Acta Otolaryngol,1991,481(Suppl):617.
18 Boleas-Aguirre MS,Lin FR,Della Santina CC,et al.Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease[J].Otol Neurotol,2008,29:33.
19 Garduno-Anaya MA,Couthino De Toledo H,HinojosaGonzalez R,et al.Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease:a twoyear prospective,placebo-controlled,double-blind,randomized trial[J].Otolaryngol Head Neck Surg,2005,133:285.
20 Licameli G,Johnston P,Luz J,et al.Phosphorylcholine-coated antibiotic tympanostomy tubes:are posttube placement complications reduced[J].Int J Pediatr Otorhinolaryngol,2008,72:1 323.
21 Silverstein H,Jackson LE,Rosenberg SI.Silverstein Microwick(TM)for treatment of inner ear disease[J].Operative Techniques in Otolaryngology-Head and Neck Surgery,2001,12:144.
22 Light JP,Silverstein H.Transtympanic perfusion:indications and limitations[J].Curr Opin Otolaryngol Head Neck Surg,2004,12:378.
23 Van Wijck F,Staecker H,Lefebvre PP.Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment[J].Acta Otolaryngol,2007,127:1 012.
24 Plontke SK,Zimmermann R,Zenner HP,et al.Technical note on microcatheter implantation for local inner ear drug delivery:surgical technique and safety aspects[J].Otol Neurotol,2006,27:912.
25 Paulson DP,Abuzeid W,Jiang H,et al.A novel controlled local drug delivery system for inner ear disease[J].Laryngoscope 2008,118:706.
26 Lee KY,Nakagawa T,Okano T,et al.Novel therapy for hearing loss:delivery of insulin-like growth factor 1to the cochlea using gelatin hydrogel[J].Otol Neurotol 2007,28:976.
27 Nakagawa T,Ito J.Drug delivery systems for the treatment of sensorineural hearing loss[J].Acta Otolaryngol,2007,557(Suppl):30.
28 Ge X,Jackson RL,Liu J,et al.Distribution of PLGA nanoparticles in chinchilla cochleae[J].Otolaryngol Head Neck Surg,2007,137:619.
29 Karagama YG,Rashid M,Lancaster JL,et al.Intranasal delivery of drugs to the Eustachian tube orifice[J].J Laryngol Otol,2011,125:934.
30 Peters G,Lin J,Arriaga MA,et al.Middle-ear endoscopy and trans-tympanic drug delivery using an interventional sialendoscope:feasibility study in human cadaveric temporal bones[J].J Laryngol Otol,2010,124:1 263.
31 Salt AN,Plontke SK.Local inner-ear drug delivery and pharmacokinetics[J].Drug Discov Today,2005,10:1 299.
32 Hendricks JL,Chikar JA,Crumling MA,et al.Localized cell and drug delivery for auditory prostheses[J].Hear Res,2008,242:117.
33 Richardson RT,Wise AK,Thompson BC,et al.Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons[J].Biomaterials,2009,30:2 614.
34 Brown JN,Miller JM,Altschuler RA,et al.Osmotic pump implant for chronic infusion of drugs into the inner ear[J].Hear Res,1993,70:167.
35 Hoffer ME,Allen K,Kopke RD,et al.Transtympanic versus sustained-release administration of gentamicin:kinetics,morphology,and function[J].Laryngoscope,2001,111:1 343.
36 McAllister DV,Wang PM,Davis SP,et al.Microfabricated needles for transdermal delivery of macromolecules and nanoparticles:fabrication methods and transport studies[J].Proc Natl Acad Sci USA,2003,100:13 755.
37 Prescott JH,Lipka S,Baldwin S,et al.Chronic,programmed polypeptide delivery from an implanted,multireservoir microchip device[J].Nat Biotechnol,2006,24:437.
38 Sewell WF,Borenstein JT,Chen Z,et al.Development of a microfluidics-based intracochlear drug delivery device[J].Audiology and Neurotology,2009,14:411.
29 Hajiioannou JK,Bathala S,Marnane CN.Case of perilymphatic fistula caused by medially displaced tympanostomy tube[J].The Journal of Laryngology&Otology,2009,123:928.
40 Salt AN,Plontke SK.Principles of local drug delivery to the inner ear[J].Audiol Neurotol,2009,14:350.
41 李晶兢,余力生.7.0T磁共振成像观察耳后给药促进药物进入内耳的可行性[J].中华耳鼻咽喉头颈外科杂志,2012,44:297.
42 静媛媛,余力生,李兴启.耳后注射复方倍他米松豚鼠血浆中药代动力学特征[J].听力学及言语疾病杂志,2009,17:354.
43 林运娟,余力生.大鼠耳后和肌肉注射地塞米松后内耳组织药物浓度分析[J].中国耳鼻咽喉头颈外科杂志,2009,16:381.
44 杨晓琦,余力生,马鑫.耳后注射复方倍他米松治疗顽固性低频型感音神经性聋[J].中华耳鼻咽喉头颈外科杂志,2007,42:814.